Reviewing a Function-First Approach to Designing Multispecifics & T-Cell Engagers

9:00 am - Wednesday 11th November 2026

  • Translate therapeutic intent and disease biology into fit-for-purpose multispecific architectures, rather than starting with a preferred molecular format
  • Examine how target combination, geometry, affinity, valency, and immune-cell engagement interact to determine coordinated function and therapeutic performance
  • Explore how computational, structural, and experimental workflows can be integrated to reduce design space, accelerate optimization, and improve developability and translational potential

Speakers:

Vice President, Biologics Discovery & Development
ModeX Therapeutics